Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | HIPK1 |
| Upstream (Parents) |
|---|
| (<<) TMED4 → HIPK1 |
| (<<) CDK13 → HIPK1 |
| (<<) DNAJC3 → HIPK1 |
| (<<) UBTF → HIPK1 |
| (<<) ATP6V1A → HIPK1 |
| (<<) DCAF16 → HIPK1 |
| Downstream (Children) |
|---|
| HIPK1 → PCYOX1 (>>) |
| HIPK1 → NOL9 (>>) |
| HIPK1 → STARD4 (>>) |
| HIPK1 → BTG1 (>>) |
| HIPK1 → HECTD1 (>>) |
| HIPK1 → TMED4 (>>) |
| HIPK1 → MAVS (>>) |
| HIPK1 → HM13 (>>) |
| HIPK1 → DNAJC3 (>>) |
| HIPK1 → ATM (>>) |
| HIPK1 → CBX5 (>>) |
| HIPK1 → RBMS1 (>>) |
| HIPK1 → IRF2BP2 (>>) |
| HIPK1 → ATXN7L3B (>>) |
| HIPK1 → CALR (>>) |
| HIPK1 → RBM9 (>>) |
| HIPK1 → DCAF16 (>>) |
